General enzyme cofactor binding sites for CoA and NAD-dependent enzymes

General enzyme cofactor binding sites for CoA and NAD-dependent enzymes refer to the highly conserved structural motifs, most notably the Rossmann fold, that facilitate the binding of essential metabolic cofactors like Nicotinamide Adenine Dinucleotide (NAD) and Coenzyme A (CoA) [1][3]. These sites are ubiquitous across the human proteome and are fundamental to cellular life, mediating critical redox reactions and acyl-transfer processes in pathways such as the citric acid cycle, glycolysis, and fatty acid metabolism [2][4]. Because these binding pockets share significant structural homology across diverse enzyme families, they are generally not considered viable therapeutic targets as a collective group; targeting the 'general' site would result in catastrophic non-specific inhibition of essential metabolic pathways [1][5]. However, these sites are of intense interest in drug discovery when viewed through the lens of specific enzymes. Many successful pharmacotherapies, such as statins (targeting HMG-CoA reductase) and certain antimicrobials, achieve their therapeutic effect by binding to the cofactor pocket of a specific enzyme while exploiting subtle structural variations to avoid off-target effects on other NAD or CoA-dependent proteins [4][6]. For biotech analysts, these sites represent both a major challenge in achieving drug selectivity and a rich source of validated pockets for competitive inhibitor design once specificity is engineered [1][2].

Other names

Rossmann foldDinucleotide-binding foldCofactor binding pocketNAD-binding domainCoA-binding domain

Drugs typically interact with these sites through competitive inhibition, where the small molecule occupies the pocket normally reserved for Coenzyme A or Nicotinamide Adenine Dinucleotide, thereby preventing the enzyme from executing its catalytic cycle [1][2].